Cheryl Hamilton Jaworski, MD | |
2670 Crain Hwy, Suite 501, Waldorf, MD 20601-2806 | |
(301) 843-0968 | |
(301) 885-0961 |
Full Name | Cheryl Hamilton Jaworski |
---|---|
Gender | Female |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 2670 Crain Hwy, Waldorf, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144312034 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | D0037399 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cheryl Hamilton Jaworski, MD 2670 Crain Hwy, Suite 501, Waldorf, MD 20601-2806 Ph: (301) 843-0968 | Cheryl Hamilton Jaworski, MD 2670 Crain Hwy, Suite 501, Waldorf, MD 20601-2806 Ph: (301) 843-0968 |
News Archive
The Centre for Neglected Tropical Diseases (CNTD) at the Liverpool School of Tropical Medicine has been awarded £10 million by the UK Department for International Development (DFID) to support endemic countries in tackling lymphatic filariasis (LF) - a crippling disease more commonly known as elephantiasis.
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the first quarter ended March 31, 2011.
The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.
Scientists at Aston University (UK) have identified a new mechanism responsible for regulating the flow of water into and out of cells. This discovery will improve understanding of how the body maintains its water balance in health and disease.
A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug.
› Verified 5 days ago
Dr. Baljeet S Sethi, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 11350 Pembrooke Sq, Suite 312, Waldorf, MD 20603 Phone: 301-843-0803 Fax: 301-645-1201 | |
Dr. James Egan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11680 Doolittle Dr, Suite 111, Waldorf, MD 20602 Phone: 240-607-2756 Fax: 240-607-2776 | |
Dr. Sandra Lee Zucker Salan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13464 Holly Spring Dr, Waldorf, MD 20601 Phone: 301-843-1868 Fax: 301-374-9742 | |
Dr. Olukemi Ajayi Olugemo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11637 Terrace Dr, Suite 100, Waldorf, MD 20602 Phone: 301-870-7287 | |
S Krishna Nandipati, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3500 Old Washington Rd, Suite 202, Waldorf, MD 20602 Phone: 301-843-2222 Fax: 301-843-2355 | |
Rehana A Hussain, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7 Post Office Road, Suite A, Waldorf, MD 20602 Phone: 301-893-0666 Fax: 301-893-1604 |